导航球囊扩张鼻额管治疗复发性气压创伤性和感染性额窦炎。
Treatment of recurrent barotraumatic and infectious frontal sinusitis by navigated balloon dilation of the nasofrontal duct.
文献信息
| PMID | 42855331 |
|---|---|
| 原文 | 在 PubMed 查看原文 ↗ |
| 发表日期 | 2026 |
| 作者 | M Bonnin |
| 作者单位 | Département de Rhinologie et de Chirurgie Plastique, CHU Bordeaux, Hôpital Pellegrin, Centre F-X Michelet, Place Raba-Léon, 33076 Bordeaux, France. |
| 期刊 | European annals of otorhinolaryngology, head and neck diseases |
| SCI 分区 | Q2 |
| IF | 1.7 |
| 研究类型 | 临床研究 · 临床 |
| 所属专科 | 鼻科 |
中文摘要
引言： 复发性气压创伤性或孤立性感染性额窦炎与鼻额管（NFD）的解剖变异有关。前筛窦切除术是标准治疗方法，但在50-80%的病例中不完整，并导致19%的狭窄率。NFD球囊扩张可能是一种替代方法。
目的： 本研究的主要目的是评估该装置的安全性。次要目的是分析其长期疗效。
材料和方法： 这是一项回顾性单中心研究，纳入接受导航扩张球囊扩大NFD治疗的患者。收集以下数据：术前和术后症状、术前CT扫描、随访时间、恢复活动、不良反应和并发症、额外治疗以及患者满意度。
结果： 共纳入21例患者：10例复发性孤立性感染性鼻窦炎和11例复发性气压创伤性鼻窦炎（27个额窦）。有1例眼睑瘀斑，无脑脊液漏。平均随访时间为36.3±38个月。91%的患者能够恢复涉及压力变化的活动。没有人需要住院、重复就诊或手术翻修。4例患者出现症状复发，其中2例的原因与额窦无关。86%的患者对手术满意，9.5%持无所谓态度，只有1例患者不满意（头痛复发）。
结论： 导航球囊扩张NFD是这两种适应证的安全有效的治疗选择，并可能取代筛窦切除术作为一线手术。
英文摘要
INTRODUCTION: Recurrent barotraumatic or isolated infectious frontal sinusitis is linked to anatomical variants of the nasofrontal duct (NFD). Anterior ethmoidectomy, the standard treatment, is incomplete in 50-80% of cases, incurring a 19% rate of stenosis. Balloon dilation of the NFD could be an alternative.
OBJECTIVES: The primary study objective was to evaluate the safety of the device. The secondary objective was to analyze its long-term efficacy.
MATERIALS AND METHODS: This was a retrospective single-center study including patients treated by NFD enlargement using a navigated dilation balloon. The following data were collected: pre- and post-operative symptoms, preoperative CT scans, follow-up time, return to activities, adverse effects and complications, additional care, and patient satisfaction.
RESULTS: Twenty-one patients were included: 10 with recurrent isolated infectious sinusitis and 11 with recurrent barotraumatic sinusitis (27 frontal sinuses). There was 1 case of eyelid ecchymosis, and no CSF leaks. Mean follow-up was 36.3±38 months. Ninety-one percent of patients were able to resume their activities involving pressure variations. None required hospitalization, repeat consultation or surgical revision. Four patients experienced symptom recurrence, including 2 for reasons other than the frontal sinus. 86% of patients were satisfied with the procedure, 9.5% were indifferent, and only 1 patient was dissatisfied (recurrence of headaches).
CONCLUSION: Navigated balloon dilation of the NFD was a safe and effective treatment option for these two indications and could replace ethmoidectomy as a first-line procedure.